• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Anthem Biosciences Limited — Updates, 05-02-2026: General Updates

    05-02-2026 | 02:38 pm

    Anthem Biosciences approved Q3 & 9M financial results. Consolidated revenue hit 423.15 Cr, with a 92.82 Cr profit, affected by a 25.37 Cr exceptional provision. The company also allotted 1,03,800 equity shares under its ESOP 2024, increasing its paid-up capital.

    No comments yet. Be the first to comment!

    All announcements from Anthem Biosciences Limited